Modulators Of Dnm2 Expression Freier; Susan M. ; et al. [Ionis Pharmaceuticals, Inc.]

U.S. Patent Application 20190241896 for Modulators Of Dnm2 Expression

A DNM2 Centronuclear Myopathy Mutation Reveals a Link between Recycling Endosome Scission and Autophagy - ScienceDirect

Isomer Separation with Vocus Ion Mobility Spectrometry - TOFWERK

Isomer Separation with Vocus Ion Mobility Spectrometry - TOFWERK

JCI Insight - Physiological impact and disease reversion for the severe form of centronuclear myopathy linked to dynamin

EP0517796B1 - Oligonucleotide analogs - Google Patents

EP0777674B1 - Polynucleotide reagents having nonnucleotidic moieties, and associated methods of synthesis and use - Google Patents

Frontiers Integrating the potential of ion mobility spectrometry-mass spectrometry in the separation and structural characterisation of lipid isomers

EPIX: Multiple Ongoing Studies of EPI-7386…

A DNM2 Centronuclear Myopathy Mutation Reveals a Link between Recycling Endosome Scission and Autophagy - ScienceDirect

Brett P. Monia's research works Ionis Pharmaceuticals, Carlsbad and other places

Assembly and disassembly dynamics of nonmuscle myosin II control endosomal fission - ScienceDirect

Shuling GUO, Director, Doctor of Philosophy, Ionis Pharmaceuticals, Carlsbad, Antisense Drug Discovery

Brett P. Monia's research works Ionis Pharmaceuticals, Carlsbad and other places

Molecular probes for the human adenosine receptors